| CXSL2200622 | BPB-101双抗注射液 | BPB-101 | Injection | Biological Products(1) | New Drug Application | 2022-12-29 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHS2400039 | 酒石酸泰贝西利胶囊 | BPI-16350 | Capsule | Chemical Drugs(1) | New Drug Application | 2024-05-01 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101669 | BPI-442096片 | BPI-442096 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-11-19 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHB2300062 | BPI-421286胶囊 | BPI-421286 | Capsule | Chemical Drugs(1) | Supplementary Application | 2023-03-14 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101238 | BPI-23314片 | BPI-23314 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-06-28 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2401264 | BPI-452080片 | BPI-452080 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-11-21 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101649 | BPI-371153胶囊 | BPI-371153 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-11-12 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHS2101029 | 盐酸恩沙替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(2.4) | New Drug Application | 2021-07-13 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200824 | BPI-460372片 | BPI-460372 | Tablet | Chemical Drugs(1) | New Drug Application | 2022-10-21 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2400010 | BPI-520105片 | BPI-520105 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-01-05 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200962 | BPI-472372片 | BPI-472372 | Tablet | Chemical Drugs(1) | New Drug Application | 2022-12-29 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHB2400014 | BPI-460372片 | BPI-460372 | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-11 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHB2101065 | BPI-421286胶囊 | BPI-421286 | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-07-06 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2101239 | BPI-23314片 | BPI-23314 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-06-28 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2401265 | BPI-452080片 | BPI-452080 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-11-21 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200825 | BPI-460372片 | BPI-460372 | Tablet | Chemical Drugs(1) | New Drug Application | 2022-10-21 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHB2300061 | BPI-421286胶囊 | BPI-421286 | Capsule | Chemical Drugs(1) | Supplementary Application | 2023-03-14 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHL2200897 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2022-11-15 | | Betta Pharmaceuticals Co Ltd | | | view |
| CXHB2300161 | BPI-452080片 | BPI-452080 | Tablet | Chemical Drugs(1) | Supplementary Application | 2023-08-17 | | Betta Pharmaceuticals Co Ltd | | | view |
| JXSL2101015 | 泽弗利单抗注射液 | zalifrelimab | Injection | Biological Products(1) | Import Drug Application | 2021-04-27 | | Betta Pharmaceuticals Co Ltd | | | view |
